First Bancorp (NASDAQ:FBNC – Get Free Report) had its target price lifted by stock analysts at Piper Sandler from $65.00 to $66.00 in a research note issued to investors on Thursday, Benzinga reports. The brokerage currently has a “neutral” rating on the financial services provider’s stock. Piper Sandler’s price objective suggests a potential upside of […]

Private Bancorp (NASDAQ:PBAM – Get Free Report) had its price objective lifted by stock analysts at DA Davidson from $105.00 to $107.00 in a research note issued on Tuesday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. DA Davidson’s target price indicates a potential upside of 23.96% from the stock’s current […]

Gilead Sciences (NASDAQ:GILD – Get Free Report) had its target price raised by Bank of America from $168.00 to $172.00 in a note issued to investors on Tuesday, Benzinga reports. The brokerage currently has a “buy” rating on the biopharmaceutical company’s stock. Bank of America‘s price objective indicates a potential upside of 12.37% from the […]

Simmons First National (NASDAQ:SFNC – Get Free Report) had its price objective increased by DA Davidson from $24.00 to $25.00 in a report released on Monday, Benzinga reports. The firm currently has a “neutral” rating on the bank’s stock. DA Davidson’s price objective indicates a potential upside of 12.54% from the company’s current price. Several […]

Kodiak Sciences (NASDAQ:KOD – Free Report) had its price objective increased by HC Wainwright from $96.00 to $126.00 in a research note published on Monday, Marketbeat.com reports. HC Wainwright currently has a buy rating on the stock. Several other research firms also recently issued reports on KOD. Lifesci Capital boosted their price objective on shares […]

Zebra Technologies (NASDAQ:ZBRA – Get Free Report) had its price target boosted by investment analysts at Barclays from $410.00 to $416.00 in a report released on Monday, Benzinga reports. The brokerage currently has an “overweight” rating on the industrial products company’s stock. Barclays‘s target price would suggest a potential upside of 7.67% from the company’s […]

Tempus AI (NASDAQ:TEM – Get Free Report) had its target price boosted by equities research analysts at Canaccord Genuity Group from $80.00 to $95.00 in a research note issued to investors on Monday, Benzinga reports. The brokerage currently has a “buy” rating on the stock. Canaccord Genuity Group’s price objective would suggest a potential upside […]

Tempus AI (NASDAQ:TEM – Get Free Report) had its target price boosted by equities research analysts at Canaccord Genuity Group from $80.00 to $95.00 in a research note issued to investors on Monday, Benzinga reports. The brokerage currently has a “buy” rating on the stock. Canaccord Genuity Group’s price objective would suggest a potential upside […]